Why the study?
Does a distal embolic protection device reduce major adverse events during percutaneous intervention of saphenous vein aorto-coronary bypass grafts?
Does a distal embolic protection device reduce major adverse events during percutaneous intervention of saphenous vein aorto-coronary bypass grafts?
The use of a distal embolic protection device during saphenous vein graft stenting significantly reduces major adverse cardiac events.
Supports routine distal protection in SVG stenting; confirms embolic protection benefit in high-risk graft PCI.
Use of this distal protection device during stenting of stenotic venous grafts was associated with a highly significant reduction in major adverse events compared with stenting over a conventional angioplasty guidewire. This demonstrates the importance of distal embolization in causing major adverse cardiac events and the value of embolic protection devices in preventing such complications.
No takes yet. Share an insight, caveat, or question.
Baim et al. (2002) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: